Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches
Version 2 2021-04-28, 11:39Version 2 2021-04-28, 11:39
Version 1 2018-03-28, 13:12Version 1 2018-03-28, 13:12
figure
posted on 2021-04-28, 11:39authored byDaniel Serrano, Christopher B. Atzinger, Marc F. Botteman
The above summary slide and plain language summary represent the opinions of the authors. For a full list of
declarations, including funding and author disclosure statements, please see
the full text online (see “read the peer-reviewed publication” opposite).